CVAC
CureVac N.V.
$5.34
-$0.02(-0.37%)
45
Overall
--
Value
60
Tech
31
Quality
Market Cap
$1.20B
Volume
586.75K
52W Range
$2.37 - $5.72
Target Price
$4.30
Order:
Income Statement
| Metric | Trend | Chart | 2023 Dec | 2024 Dec |
|---|---|---|---|---|
| REVENUE | ||||
| Total Revenue | $53.8M | $535.2M | ||
| Total Revenue | $53.8M | $535.2M | ||
| COST OF GOODS SOLD | ||||
| Cost of Revenue | $124.4M | $105.8M | ||
| GROSS PROFIT | ||||
| Gross Profit | $-70.6M | $429.4M | ||
| OPERATING EXPENSES | ||||
| Operating Expenses | $212.8M | $260.6M | ||
| Research & Development | $115.7M | $153.0M | ||
| Research Expense | $115.7M | $153.0M | ||
| Selling, General & Administrative | $95.7M | $74.1M | ||
| Selling & Marketing Expenses | $3.9M | $4.4M | ||
| General & Administrative Expenses | $91.8M | $69.7M | ||
| Salaries & Wages | $72.3M | -- | ||
| Depreciation & Amortization | $22.4M | -- | ||
| Depreciation & Amortization | $22.4M | -- | ||
| Amortization | $22.4M | -- | ||
| Other Operating Expenses | $1.4M | $33.4M | ||
| OPERATING INCOME | ||||
| Operating income | $-283.4M | $168.8M | ||
| EBITDA | $-234.1M | $210.5M | ||
| NON-OPERATING ITEMS | ||||
| Interest Expense (Non-Operating) | $2.5M | $829.0K | ||
| Interest Income Operating | $9.2M | $8.9M | ||
| Intinc | $16.7M | $14.0M | ||
| Net Non-Operating Interest Income/Expense | $14.2M | $13.2M | ||
| Other Income/Expense | $2.1M | -- | ||
| Other Special Charges | $8.0M | -- | ||
| PRE-TAX INCOME | ||||
| EBIT | $-257.5M | $191.7M | ||
| Pre-Tax Income | $-260.0M | $190.9M | ||
| INCOME TAX | ||||
| Tax Provision | $198.0K | $28.7M | ||
| NET INCOME | ||||
| Net Income | $-260.2M | $162.2M | ||
| Net Income (Continuing Operations) | $-260.2M | $162.2M | ||
| Net Income (Discontinued Operations) | $-260.2M | $162.2M | ||
| Net Income (Common Stockholders) | $-260.2M | $162.2M | ||
| Normalized Income | $-191.1M | $189.0M | ||
| TOTALS | ||||
| Total Expenses | $337.1M | $366.4M | ||
| SHARE & EPS DATA | ||||
| Average Shares Outstanding | $220.9M | $224.4M | ||
| Average Shares Outstanding (Diluted) | $220.9M | $224.4M | ||
| Shares Outstanding | $224.3M | $224.3M | ||
| Basic EPS | $-1.18 | $0.72 | ||
| Basic EPS (Continuing Operations) | $-1.18 | $0.72 | ||
| Diluted EPS | $-1.18 | $0.72 | ||
| Diluted EPS (Continuing Operations) | $-1.18 | $0.72 | ||
| OTHER METRICS | ||||
| Gain On Sale Of P P E | $1.2M | -- | ||
| Other Costof Revenue | $124.4M | $105.8M | ||
| Other Gand A | $91.8M | $69.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CVAC | $5.34 | -0.4% | 586.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |